Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response ☆
Titel:
Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response ☆
Auteur:
Loibl, S. Schneeweiss, A. Huober, J. Braun, M. Rey, J. Blohmer, J.-U. Furlanetto, J. Zahm, D.-M. Hanusch, C. Thomalla, J. Jackisch, C. Staib, P. Link, T. Rhiem, K. Solbach, C. Fasching, P.A. Nekljudova, V. Denkert, C. Untch, M.